123 related articles for article (PubMed ID: 10405512)
1. Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use.
Martin A; Scahill L; Klin A; Volkmar FR
J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):923-31. PubMed ID: 10405512
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use.
Aman MG; Van Bourgondien ME; Wolford PL; Sarphare G
J Am Acad Child Adolesc Psychiatry; 1995 Dec; 34(12):1672-81. PubMed ID: 8543539
[TBL] [Abstract][Full Text] [Related]
3. Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.
de Bildt A; Mulder EJ; Scheers T; Minderaa RB; Tobi H
Pediatrics; 2006 Dec; 118(6):e1860-6. PubMed ID: 17142506
[TBL] [Abstract][Full Text] [Related]
4. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
5. MRI-based morphometry in children with multiple complex developmental disorder, a phenotypically defined subtype of pervasive developmental disorder not otherwise specified.
Lahuis BE; Durston S; Nederveen H; Zeegers M; Palmen SJ; Van Engeland H
Psychol Med; 2008 Sep; 38(9):1361-7. PubMed ID: 17825125
[TBL] [Abstract][Full Text] [Related]
6. Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study.
McDougle CJ; Holmes JP; Bronson MR; Anderson GM; Volkmar FR; Price LH; Cohen DJ
J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):685-93. PubMed ID: 9136504
[TBL] [Abstract][Full Text] [Related]
7. Cognitive and symptom profiles in Asperger's syndrome and high-functioning autism.
Koyama T; Tachimori H; Osada H; Takeda T; Kurita H
Psychiatry Clin Neurosci; 2007 Feb; 61(1):99-104. PubMed ID: 17239046
[TBL] [Abstract][Full Text] [Related]
8. Regression of language and non-language skills in pervasive developmental disorders.
Meilleur AA; Fombonne E
J Intellect Disabil Res; 2009 Feb; 53(2):115-24. PubMed ID: 19054269
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of irritability in pervasive developmental disorders.
Stigler KA; McDougle CJ
Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
[TBL] [Abstract][Full Text] [Related]
10. Pervasive developmental disorder and childhood-onset schizophrenia: comorbid disorder or a phenotypic variant of a very early onset illness?
Sporn AL; Addington AM; Gogtay N; Ordoñez AE; Gornick M; Clasen L; Greenstein D; Tossell JW; Gochman P; Lenane M; Sharp WS; Straub RE; Rapoport JL
Biol Psychiatry; 2004 May; 55(10):989-94. PubMed ID: 15121482
[TBL] [Abstract][Full Text] [Related]
11. Modeling clinical outcome of children with autistic spectrum disorders.
Coplan J; Jawad AF
Pediatrics; 2005 Jul; 116(1):117-22. PubMed ID: 15995041
[TBL] [Abstract][Full Text] [Related]
12. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
[TBL] [Abstract][Full Text] [Related]
13. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
Fombonne E; Zakarian R; Bennett A; Meng L; McLean-Heywood D
Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529
[TBL] [Abstract][Full Text] [Related]
14. Use of psychotropic medication in children and adolescents with autism spectrum disorders.
Coury DL; Anagnostou E; Manning-Courtney P; Reynolds A; Cole L; McCoy R; Whitaker A; Perrin JM
Pediatrics; 2012 Nov; 130 Suppl 2():S69-76. PubMed ID: 23118256
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of bipolar disorder comorbidity in adolescents and young adults with high-functioning autism spectrum disorder: a preliminary study of 44 outpatients.
Munesue T; Ono Y; Mutoh K; Shimoda K; Nakatani H; Kikuchi M
J Affect Disord; 2008 Dec; 111(2-3):170-5. PubMed ID: 18378000
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic criteria of autism and Asperger's syndrome: similarities and differences].
Poirier N; Forget J
Sante Ment Que; 1998; 23(1):130-48. PubMed ID: 9775958
[TBL] [Abstract][Full Text] [Related]
17. [Pervasive developmental disorders: controversies concerning the classification of autism].
Pisula E
Psychiatr Pol; 2000; 34(3):447-55. PubMed ID: 11055183
[TBL] [Abstract][Full Text] [Related]
18. Reliability and accuracy of differentiating pervasive developmental disorder subtypes.
Mahoney WJ; Szatmari P; MacLean JE; Bryson SE; Bartolucci G; Walter SD; Jones MB; Zwaigenbaum L
J Am Acad Child Adolesc Psychiatry; 1998 Mar; 37(3):278-85. PubMed ID: 9519632
[TBL] [Abstract][Full Text] [Related]
19. [Sixty years of autism].
van Berckelaer-Onnes IA
Ned Tijdschr Geneeskd; 2004 May; 148(21):1024-30. PubMed ID: 15185436
[TBL] [Abstract][Full Text] [Related]
20. Asperger's syndrome: diagnosis, treatment, and outcome.
Szatmari P
Psychiatr Clin North Am; 1991 Mar; 14(1):81-93. PubMed ID: 2047334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
